HRP20211173T1 - Uporaba probiotika u liječenju i/ili prevenciji psorijaze - Google Patents
Uporaba probiotika u liječenju i/ili prevenciji psorijaze Download PDFInfo
- Publication number
- HRP20211173T1 HRP20211173T1 HRP20211173TT HRP20211173T HRP20211173T1 HR P20211173 T1 HRP20211173 T1 HR P20211173T1 HR P20211173T T HRP20211173T T HR P20211173TT HR P20211173 T HRP20211173 T HR P20211173T HR P20211173 T1 HRP20211173 T1 HR P20211173T1
- Authority
- HR
- Croatia
- Prior art keywords
- psoriasis
- prevention
- preparation
- treatment
- outbreaks
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title claims 32
- 239000006041 probiotic Substances 0.000 title claims 16
- 235000018291 probiotics Nutrition 0.000 title claims 16
- 230000002265 prevention Effects 0.000 title claims 13
- 230000000529 probiotic effect Effects 0.000 claims 15
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims 8
- 241001608472 Bifidobacterium longum Species 0.000 claims 8
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims 7
- 244000005700 microbiome Species 0.000 claims 4
- 239000008267 milk Substances 0.000 claims 3
- 235000013336 milk Nutrition 0.000 claims 3
- 210000004080 milk Anatomy 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 241001134770 Bifidobacterium animalis Species 0.000 claims 1
- 241000131482 Bifidobacterium sp. Species 0.000 claims 1
- 206010015278 Erythrodermic psoriasis Diseases 0.000 claims 1
- 241000170280 Kluyveromyces sp. Species 0.000 claims 1
- 241000186610 Lactobacillus sp. Species 0.000 claims 1
- 206010028703 Nail psoriasis Diseases 0.000 claims 1
- 206010037575 Pustular psoriasis Diseases 0.000 claims 1
- 241000235088 Saccharomyces sp. Species 0.000 claims 1
- 241000194022 Streptococcus sp. Species 0.000 claims 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 229940118852 bifidobacterium animalis Drugs 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 230000001055 chewing effect Effects 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000015140 cultured milk Nutrition 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000015203 fruit juice Nutrition 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 206010018797 guttate psoriasis Diseases 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000012669 liquid formulation Substances 0.000 claims 1
- 235000013622 meat product Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 235000010603 pastilles Nutrition 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- -1 sachets Substances 0.000 claims 1
- 210000004761 scalp Anatomy 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 235000015192 vegetable juice Nutrition 0.000 claims 1
- 235000013618 yogurt Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Claims (14)
1. Probiotički pripravak koji sadrži Bifidobacterium animalis subsp. lactis (B. lactis), Bifidobacterium longum i Lactobacillus rhamnosus za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze, pri čemu B. lactis je B. lactis CECT 8145, B. longum je B. longum ES1 CECT 7347 i L. rhamnosus je L. rhamnosus CECT 8361.
2. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 1, naznačen time što je izbijanje psorijaze ili psorijaza odabrano iz skupine koja se sastoji od psorijaze plaka, palmarno-plantarne psorijaze, psorijaze vlasišta, psorijaze noktiju, psorijaze na licu, psorijaze u naborima, guttatne psorijaze, eritrodermične psorijaze i pustulozne psorijaze.
3. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 1 ili 2 naznačen time što je probiotički pripravak farmaceutski pripravak ili hranjivi pripravak.
4. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 3, naznačen time što farmaceutski pripravak sadrži farmaceutski prihvatljiv nosač i/ili pomoćnu tvar.
5. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 3 ili 4, naznačen time što je farmaceutski pripravak formuliran za primjenu u tekućem ili u krutom obliku.
6. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 5, naznačen time što je kruta formulacija odabrana iz skupine koja se sastoji od tableta, pastila, slatkiša, tableta za žvakanje, žvakaćih guma, kapsula, vrećica, prašaka, granula, obloženih čestica ili obloženih tableta, tableta i gastrorezistentnih tableta i kapsula i disperzibilnih traka i filmova.
7. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 5, naznačen time što je tekuća formulacija odabrana iz skupine koja se sastoji od oralnih otopina, suspenzija, emulzija i sirupa.
8. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 3, naznačen time što je hranjivi pripravak hrana ili prehrambeni dodatak.
9. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema zahtjevu 8, naznačen time što je hrana odabrana iz skupine koja se sastoji od sokova od voća ili povrća, sladoleda, adaptirane mliječne hrane, mlijeka, jogurta, sira, fermentiranog mlijeka, mlijeka u prahu, žitarica, pekarskih proizvoda, proizvoda na bazi mlijeka, mesnih proizvoda i pića.
10. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema bilo kojem zahtjevu od 1 do 9, naznačen time što pripravak nadalje sadrži mikroorganizam odabran iz skupine koja se sastoji od Lactobacillus sp., Streptococcus sp., Bifidobacterium sp., Saccharomyces sp., Kluyveromyces sp. i njihove kombinacije.
11. Probiotički pripravak za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze prema bilo kojem od zahtjeva 1 do 10, naznačen time što je ukupna koncentracija mikroorganizama sojeva B. lactis, L. rhamnosus i B. longum u pripravku između 103 i 1012 cfu, poželjno 109 cfu.
12. Probiotički pripravak koji sadrži mikroorganizme Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum i Lactobacillus rhamnosus, pri čemu je koncentracija B. longum s obzirom na ukupnu koncentraciju mikroorganizama prisutnih u pripravku najmanje 30%, poželjno najmanje 35% i B. lactis je B. lactis CECT 8145, B. longum je B. longum ES1 CECT 7347 i L. rhamnosus je L. rhamnosus CECT 8361.
13. Probiotički pripravak prema zahtjevu 12 za uporabu kao lijek.
14. Probiotički pripravak prema zahtjevu 12 za uporabu u liječenju i/ili prevenciji izbijanja psorijaze i/ili psorijaze.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16382122.6A EP3222282A1 (en) | 2016-03-21 | 2016-03-21 | Use of probiotics in the treatment and/or prevention of psoriasis |
EP17722689.1A EP3432899B1 (en) | 2016-03-21 | 2017-03-21 | Use of probiotics in the treatment and/or prevention of psoriasis |
PCT/EP2017/056719 WO2017162683A1 (en) | 2016-03-21 | 2017-03-21 | Use of probiotics in the treatment and/or prevention of psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20211173T1 true HRP20211173T1 (hr) | 2021-10-15 |
Family
ID=55969084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20211173TT HRP20211173T1 (hr) | 2016-03-21 | 2021-07-22 | Uporaba probiotika u liječenju i/ili prevenciji psorijaze |
Country Status (25)
Country | Link |
---|---|
US (1) | US10912802B2 (hr) |
EP (2) | EP3222282A1 (hr) |
KR (1) | KR102303587B1 (hr) |
CN (1) | CN110325198B (hr) |
AR (1) | AR107921A1 (hr) |
BR (1) | BR112018069284A2 (hr) |
CA (1) | CA3018625A1 (hr) |
DK (1) | DK3432899T3 (hr) |
EA (1) | EA201891908A1 (hr) |
ES (1) | ES2873889T3 (hr) |
HR (1) | HRP20211173T1 (hr) |
HU (1) | HUE055635T2 (hr) |
IL (1) | IL261932B2 (hr) |
MA (1) | MA43488B1 (hr) |
MX (1) | MX2018011593A (hr) |
MY (1) | MY193275A (hr) |
PE (1) | PE20190432A1 (hr) |
PH (1) | PH12018502042A1 (hr) |
PL (1) | PL3432899T3 (hr) |
PT (1) | PT3432899T (hr) |
RS (1) | RS62101B1 (hr) |
RU (1) | RU2767967C2 (hr) |
SI (1) | SI3432899T1 (hr) |
UA (1) | UA127180C2 (hr) |
WO (1) | WO2017162683A1 (hr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800002052A1 (it) | 2018-01-26 | 2019-07-26 | Girolamo Stefano Di | Probiotico per il trattamento della psoriasi |
EP3851115A1 (en) * | 2020-01-15 | 2021-07-21 | Biopolis, S.L. | Probiotic composition for its use as an antioxidant |
US20210275612A1 (en) * | 2020-03-09 | 2021-09-09 | Glac Biotech Co., Ltd. | Method for alleviating inflammation-related disorder |
CN113142554A (zh) * | 2020-06-09 | 2021-07-23 | 江苏佰澳达生物科技有限公司 | 一种改善头皮屑产生的益生菌发酵液及其应用 |
EP3967318A1 (en) * | 2020-09-14 | 2022-03-16 | Bionou Research, S.L. | Probiotic compositions for the treatment of acne |
CN112159778B (zh) * | 2020-09-30 | 2021-12-03 | 江南大学 | 一株可缓解银屑病的动物双歧杆菌及其应用 |
WO2022090474A1 (en) * | 2020-10-29 | 2022-05-05 | Deerland Probiotics & Enzymes A/S | Microencapsulated microbial composition |
CN112546074B (zh) * | 2020-12-24 | 2022-09-27 | 江南大学 | 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用 |
CN112812989B (zh) * | 2020-12-31 | 2022-06-10 | 江南大学 | 一种能够缓解银屑病的青春双歧杆菌及其应用 |
CN113088473B (zh) * | 2021-04-27 | 2022-08-02 | 江南大学 | 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌 |
CN113455549B (zh) * | 2021-06-29 | 2022-09-13 | 黑龙江飞鹤乳业有限公司 | 一种奶酪产品及其制备方法和应用 |
AU2022410395A1 (en) * | 2021-12-16 | 2024-06-06 | Biopolis, S. L. | Use of postbiotics in the treatment and/or prevention of anxiety disorders |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0307839A (pt) * | 2002-02-21 | 2004-12-07 | Nestle Sa | Composição fotoprotetora para a pele que pode ser administrada por via oral |
JP2004250337A (ja) | 2003-02-18 | 2004-09-09 | Sunstar Inc | アレルギー疾患改善用製剤 |
DK1951273T3 (da) * | 2005-10-06 | 2014-05-05 | Probi Ab | Anvendelse af lactobacillus til behandling af autoimmune sygdomme |
ZA200802935B (en) * | 2005-10-06 | 2009-11-25 | Brobi Ab | Use of lactobacillus for treatment of autoimmune diseases |
ES2343499B1 (es) * | 2007-12-24 | 2011-06-10 | Consejo Superior De Investigaciones Cientificas | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten. |
ES2702490T3 (es) * | 2011-05-03 | 2019-03-01 | Dupont Nutrition Biosci Aps | Bacterias probióticas para el tratamiento tópico de trastornos de la piel |
KR20130049554A (ko) | 2011-11-04 | 2013-05-14 | 주식회사 쎌바이오텍 | 아토피 예방 또는 치료용 조성물 |
KR101453982B1 (ko) * | 2012-09-19 | 2014-10-28 | 주식회사 쎌바이오텍 | 과민성 대장 증후군 예방 또는 치료용 조성물 |
ES2526986B1 (es) * | 2013-07-18 | 2015-11-02 | Biopolis, S.L. | Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
KR101724601B1 (ko) | 2014-11-04 | 2017-04-10 | 주식회사 쎌바이오텍 | 아토피 예방 또는 치료용 조성물 |
ES2575828B1 (es) * | 2014-12-31 | 2017-07-07 | Universidad De León | Empleo de probióticos en el incremento de la fertilidad masculina |
TWI790189B (zh) * | 2015-01-02 | 2023-01-21 | 美商梅拉洛伊卡公司 | 細菌組成物 |
-
2016
- 2016-03-21 EP EP16382122.6A patent/EP3222282A1/en not_active Withdrawn
-
2017
- 2017-03-20 AR ARP170100679A patent/AR107921A1/es unknown
- 2017-03-21 PE PE2018001857A patent/PE20190432A1/es unknown
- 2017-03-21 ES ES17722689T patent/ES2873889T3/es active Active
- 2017-03-21 RS RS20210883A patent/RS62101B1/sr unknown
- 2017-03-21 US US16/087,584 patent/US10912802B2/en active Active
- 2017-03-21 SI SI201730861T patent/SI3432899T1/sl unknown
- 2017-03-21 HU HUE17722689A patent/HUE055635T2/hu unknown
- 2017-03-21 DK DK17722689.1T patent/DK3432899T3/da active
- 2017-03-21 CN CN201780030657.4A patent/CN110325198B/zh active Active
- 2017-03-21 EP EP17722689.1A patent/EP3432899B1/en active Active
- 2017-03-21 CA CA3018625A patent/CA3018625A1/en active Pending
- 2017-03-21 UA UAA201810096A patent/UA127180C2/uk unknown
- 2017-03-21 BR BR112018069284-0A patent/BR112018069284A2/pt active Search and Examination
- 2017-03-21 PL PL17722689T patent/PL3432899T3/pl unknown
- 2017-03-21 MX MX2018011593A patent/MX2018011593A/es unknown
- 2017-03-21 WO PCT/EP2017/056719 patent/WO2017162683A1/en active Application Filing
- 2017-03-21 MY MYPI2018703435A patent/MY193275A/en unknown
- 2017-03-21 RU RU2018136939A patent/RU2767967C2/ru active
- 2017-03-21 MA MA43488A patent/MA43488B1/fr unknown
- 2017-03-21 IL IL261932A patent/IL261932B2/en unknown
- 2017-03-21 KR KR1020187030333A patent/KR102303587B1/ko active IP Right Grant
- 2017-03-21 PT PT177226891T patent/PT3432899T/pt unknown
- 2017-03-21 EA EA201891908A patent/EA201891908A1/ru unknown
-
2018
- 2018-09-24 PH PH12018502042A patent/PH12018502042A1/en unknown
-
2021
- 2021-07-22 HR HRP20211173TT patent/HRP20211173T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20211173T1 (hr) | Uporaba probiotika u liječenju i/ili prevenciji psorijaze | |
HRP20210995T1 (hr) | Uporaba probiotika u liječenju i/ili prevenciji atopičnog dermatitisa | |
Govender et al. | A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation | |
US8877179B2 (en) | Frozen confections containing probiotic micro-organisms | |
Villena et al. | Probiotics for everyone! The novel immunobiotic Lactobacillus rhamnosus CRL1505 and the beginning of Social Probiotic Programs in Argentina | |
US20120141443A1 (en) | Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles | |
SI3048165T1 (en) | NEW SEV BACTERIA BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND ITS APPLICATION FOR INJURY AND / OR PREVENTION OF OVERVIEW OF BODY WEALTH AND BALANCE AND ASSOCIATED DISEASES | |
RU2004127986A (ru) | Оральная композиция для фотопротекции кожи | |
RU2004128078A (ru) | Светозащитная, предназначенная для орального приема композиция для кожи | |
Caceres et al. | Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children | |
WO2012026832A1 (en) | Process of producing shelf stable probiotic food | |
Balgir et al. | In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut | |
Bujalance et al. | Lack of correlation between in vitro antibiosis and in vivo protection against enteropathogenic bacteria by probiotic lactobacilli | |
Bunesova et al. | Comparison of mupirocin-based media for selective enumeration of bifidobacteria in probiotic supplements | |
Ozcan et al. | The use of prebiotics of plant origin in functional milk products | |
Kalliomäki et al. | Positive interactions with the microbiota: probiotics | |
Witzler et al. | Development of a potential probiotic lozenge containing Enterococcus faecium CRL 183 | |
Chon et al. | Functional characteristics of kefir as a fermented dairy product: a review | |
Kasra-Kermanshahi et al. | Probiotics and Prebiotics in medicine and dentistry | |
Mancuskova et al. | The medical functions of probiotics and their role in clinical nutrition | |
Yamaguishi et al. | Current market trends and future directions | |
Kumar et al. | Role of probiotics in health improvement: Adaptations, advantages and their uses | |
Ledina et al. | Probiotski status bakterija mlečne kiseline | |
Bilginer et al. | Probiotics and in vitro tests used for their determination. | |
Ko et al. | Selection of lactic acid bacteria suitable for manufacture of freeze-dried coffee |